GRF:BMEGrifols, S.A. Class A Analysis
Data as of 2026-03-14 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Eagle Capital Growth Fund trades at $10.59, below its 20‑day SMA (10.66) and 50‑day SMA (10.78), with the RSI at 44.9 indicating a neutral momentum. The MACD histogram is negative, signaling short‑term bearish pressure, while volume has been decreasing, raising liquidity concerns. Valuation metrics are compelling: a trailing P/E of 8.3 versus an industry average of 16.4 and a price‑to‑book of 0.89 suggest the fund is undervalued, and the 8% dividend yield (payout ratio 66.9%) adds attractive income. Insider confidence is evident as director Neal Zalenko recently bought 500 shares at $10.80, reinforcing a positive sentiment despite the modest beta of 0.39 and a 30‑day volatility of 23.6%.
Market Outlook
Short Term
< 1 yearKey Factors
- Insider purchase signals confidence in near‑term outlook
- Price is testing the support level around $10.36
- Bearish MACD histogram advises caution
Medium Term
1–3 yearsKey Factors
- Low beta (0.39) reduces exposure to market swings
- Valuation remains attractive (PE 8.3, PB 0.89) relative to peers
- High dividend yield (8%) provides steady income
Long Term
> 3 yearsKey Factors
- Sustained dividend payout supports long‑term cash flow
- Asset‑management sector offers stable earnings potential
- Undervalued pricing compared with industry averages
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.